Gregory A. Curt, MD, executive director for external relations, U.S. medical affairs, oncology, at AstraZeneca, died July 31, 2016, at the age of 64. Curt was an active AACR member since 2004. Curt was former clinical director of the National Cancer Institute (NCI) and retired captain of the United States Public Health Service (PHS).
Born in Fall River, Massachusetts, in 1952, Curt graduated from Providence College in Rhode Island and received his medical degree from the University of Rochester School of Medicine in New York. He conducted research at Dana-Farber Cancer Institute in Boston and the Charing Cross Hospital in London, and then completed his internship and residency at what is now Beth Israel Deaconess Hospital in Boston.
Curt began his career at the NCI with an oncology fellowship in 1980. While there, he conducted clinical research related to brain tumors and phase I clinical trials. Additionally, he was involved in basic research that examined drug resistance in cancer cells. Curt joined AstraZeneca in 2002 following his retirement from the PHS.
He was actively involved with the AACR for the past 12 years, serving as a speaker/mentor with the Scientist – Survivor Program, a member of the AACR Landon Prize Transitional Committee, and a participant in the Industry Roundtable.
Additionally, Curt was a member of President George H.W. Bush’s organization, the CEO Roundtable on Cancer, and editor emeritus of the journal The Oncologist. He was honored with the Outstanding Service Medal by the PHS in 1992.